• No products in the cart.

ISCTR Donation

$
 
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

Terms

Donation Total: $100.00

  • No products in the cart.

ISCTR Donation

$
 
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

Terms

Donation Total: $100.00

  /  The ISCTR – Nelson Award

nelsons-1

Established by the ISCTR Board of Directors, the ISCTR – Nelson Award for Innovation and Translation in Cardiovascular Medicine honors leaders in translational cardiovascular medicine. This video provides more information about the award and its pioneering namesakes.

ISCTR - Nelson Award

The 2019 RECIPIENT

Spencer King III, MD, MACC

 

The ISCTR Board of Directors announced that the 2019 recipient of the ISCTR-Nelson Award for Innovation and Translation in Cardiovascular Medicine is Spencer King III, MD, MACC.

“Spencer King has been a true leader in cardiology, both as a clinician and innovator and as a leader, serving as president of two essential cardiology societies. We are excited to be honoring Dr. King for his dedicated and longstanding contributions to interventional cardiology as well as to the education and support of cardiologists worldwide,” said ISCTR President, Nabil Dib, MD, MSc, FACC.

Dr. King is professor of medicine emeritus at the Emory University School of Medicine as well as former president of the Saint Joseph’s Heart and Vascular Institute in Atlanta and a director of the Saint Joseph’s Translational Research Institute. A pioneer in cardiac catheterization, coronary arteriography and interventional cardiology, Dr. King was co-developer of the multi-purpose technique of coronary arteriography and has directed invasive and interventional cardiology training for more than 150 cardiology fellows.

Dr. King served as Director of the Cardiac Catheterization Laboratory of Emory University Hospital from its inception in 1972 through 2000 and was Director of Interventional Cardiology and the Andreas Gruentzig Cardiovascular Center at Emory University from 1985 until 2000.

A participant on numerous professional organizations, Dr. King has served as President of the American College of Cardiology (1998-1999) and of the Society for Cardiac Angiography and Interventions (1990-1991) and was the first Chair of the Interventional Cardiology Boards of the American Board of Internal Medicine (1997-2007).

He was the founding Editor-in-Chief of the Journal of the American College of Cardiology: Cardiovascular Interventions, is a section editor of JACC, and is on the editorial board of several other journals. Dr. King is currently Editor-in-Chief of the American College of Cardiology Extended Learning (ACCEL) program and is chair of the New York State Cardiac Advisory Committee and editor-at-large of the CRM Journal. He has served as principal investigator or member of the steering committees of 15 national and international clinical trials in cardiology, as well as conducting the first NHLBI trial of coronary angioplasty versus bypass surgery. The author of more than 600 papers on cardiology, Dr. King has edited or co-edited 12books including Interventional Cardiology and Hurst’s The Heart.

His research interest has been in the area of restenosis prevention, having been a developer of radiation therapy to block restenosis, as well as new device development, evaluation of therapeutic approaches to cardiovascular disease, and preventive cardiology.

Among his many honors are the Lifetime Achievement Award of the TCT, the Mikamo Lecture and Honorary International Fellow of the Japan Circulation Society, the Bishop Lecture of the American College of Cardiology, the ETHICA Award of the European Society of Cardiology, the Jesse E. Edwards Lecture of the American Heart Association, the Combat Medical Badge and Bronze Star, and Distinguished Alumnus Awards from the Medical College of Georgia and Mercer University.